Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Aliza Brown

Concepts (248)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
13
2020
512
2.490
Why?
Thrombolytic Therapy
8
2020
110
1.140
Why?
Tissue Plasminogen Activator
9
2020
109
1.100
Why?
Brain Ischemia
5
2020
161
0.990
Why?
Endarterectomy, Carotid
9
2011
62
0.860
Why?
Thrombectomy
2
2020
72
0.830
Why?
Health Services Misuse
1
2020
13
0.680
Why?
Fibrinolytic Agents
7
2020
128
0.680
Why?
Tunica Intima
8
2011
55
0.670
Why?
Time-to-Treatment
1
2020
78
0.650
Why?
Patient Transfer
1
2020
99
0.650
Why?
Homocysteine
7
2011
126
0.620
Why?
Disease Models, Animal
12
2015
1478
0.560
Why?
Microbubbles
3
2011
25
0.540
Why?
Pneumonia, Viral
1
2020
178
0.540
Why?
Emergency Service, Hospital
2
2020
522
0.530
Why?
Coronavirus Infections
1
2020
188
0.530
Why?
Carotid Arteries
6
2010
77
0.520
Why?
Emergency Medical Technicians
1
2016
10
0.520
Why?
Emergency Medical Services
1
2016
114
0.480
Why?
Fluorocarbons
4
2019
61
0.480
Why?
Ultrasonic Therapy
3
2011
33
0.470
Why?
Acetaminophen
3
2011
279
0.450
Why?
Acetylcysteine
2
2011
102
0.450
Why?
Quality Improvement
1
2016
226
0.440
Why?
Cerebral Hemorrhage
3
2015
97
0.380
Why?
Rural Population
1
2016
577
0.370
Why?
Liver Failure, Acute
1
2011
56
0.360
Why?
Intracranial Embolism
2
2012
29
0.360
Why?
Rabbits
10
2016
375
0.350
Why?
Carotid Stenosis
4
2011
66
0.290
Why?
Animals
26
2016
13505
0.280
Why?
Time Factors
11
2020
2968
0.260
Why?
Neuroprotective Agents
2
2019
101
0.260
Why?
Insulin Resistance
2
2010
275
0.250
Why?
Magnetic Resonance Imaging
2
2014
1546
0.240
Why?
Platelet Aggregation Inhibitors
4
2006
181
0.200
Why?
Male
22
2020
26761
0.200
Why?
Brain
1
2010
1323
0.190
Why?
Rats
12
2011
3220
0.180
Why?
Rats, Sprague-Dawley
9
2011
1563
0.180
Why?
United States
4
2020
5192
0.180
Why?
Hyperplasia
8
2011
98
0.170
Why?
Triage
1
2020
66
0.170
Why?
Conflict of Interest
1
2020
26
0.160
Why?
Disease Outbreaks
1
2020
123
0.160
Why?
Fabry Disease
1
2019
9
0.160
Why?
Enzyme Replacement Therapy
1
2019
17
0.160
Why?
Angiography, Digital Subtraction
2
2011
27
0.160
Why?
Carotid Artery, Common
2
2011
44
0.150
Why?
Ischemic Attack, Transient
1
2019
57
0.150
Why?
Cardiology
1
2020
97
0.150
Why?
Cerebral Angiography
3
2012
87
0.140
Why?
Humans
13
2020
52483
0.140
Why?
Cohort Studies
1
2020
1542
0.130
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
3
2004
58
0.120
Why?
Middle Aged
7
2020
13028
0.120
Why?
Infarction, Anterior Cerebral Artery
1
2015
2
0.120
Why?
Pandemics
1
2020
585
0.120
Why?
Aged
6
2020
10121
0.120
Why?
Follow-Up Studies
1
2020
2279
0.120
Why?
Infarction, Middle Cerebral Artery
1
2015
40
0.120
Why?
Retrospective Studies
4
2020
6607
0.120
Why?
Female
12
2020
28171
0.120
Why?
Ticlopidine
2
2006
56
0.120
Why?
Receptors, N-Methyl-D-Aspartate
2
2005
79
0.120
Why?
Antidotes
2
2011
27
0.120
Why?
Prospective Studies
1
2020
2481
0.110
Why?
Salivary Proteins and Peptides
2
2004
8
0.110
Why?
L-Lactate Dehydrogenase
1
2014
71
0.110
Why?
Posterior Leukoencephalopathy Syndrome
1
2014
44
0.110
Why?
Fractures, Compression
1
2013
17
0.100
Why?
Fractures, Spontaneous
1
2013
15
0.100
Why?
Models, Animal
4
2011
234
0.100
Why?
Spine
1
2013
89
0.100
Why?
Treatment Outcome
5
2019
5422
0.100
Why?
Telemedicine
1
2019
494
0.100
Why?
Expectorants
1
2011
14
0.090
Why?
Analysis of Variance
2
2011
554
0.090
Why?
Echinomycin
1
2011
6
0.090
Why?
Carotid Artery Injuries
1
2011
13
0.090
Why?
Statistics as Topic
1
2011
87
0.090
Why?
Circle of Willis
1
2011
2
0.090
Why?
Sensitivity and Specificity
2
2011
891
0.090
Why?
Cerebral Infarction
1
2011
34
0.090
Why?
Ultrasonography, Doppler, Transcranial
1
2011
20
0.090
Why?
Intracranial Hemorrhages
1
2011
39
0.090
Why?
Sinus Thrombosis, Intracranial
1
2010
16
0.090
Why?
Acarbose
1
2010
2
0.090
Why?
Receptors, Adrenergic, beta-2
1
2000
16
0.090
Why?
Indocyanine Green
1
2010
33
0.090
Why?
Analgesics, Non-Narcotic
1
2011
117
0.090
Why?
Hepatocytes
1
2011
190
0.090
Why?
Estradiol
1
2011
214
0.080
Why?
Subarachnoid Hemorrhage
1
2010
60
0.080
Why?
Trachea
1
2000
57
0.080
Why?
Ultrasonography, Interventional
1
2010
140
0.080
Why?
Adult
4
2020
14161
0.080
Why?
Radiography
1
2010
470
0.080
Why?
Arkansas
3
2019
2028
0.080
Why?
Dietary Sucrose
2
2010
14
0.070
Why?
Hypoglycemic Agents
1
2010
211
0.070
Why?
Glucocorticoids
1
2000
235
0.070
Why?
Dexamethasone
1
2000
438
0.070
Why?
Cystathionine beta-Synthase
2
2004
17
0.070
Why?
Reproducibility of Results
1
2011
1229
0.070
Why?
Ketorolac Tromethamine
1
2007
2
0.070
Why?
Myocytes, Smooth Muscle
2
2005
93
0.070
Why?
Cyclooxygenase Inhibitors
1
2007
39
0.070
Why?
Recovery of Function
2
2019
199
0.070
Why?
Cerebral Veins
1
2007
17
0.070
Why?
Mice
3
2011
5949
0.070
Why?
Drug Administration Schedule
2
2019
374
0.070
Why?
Cerebral Arteries
1
2007
30
0.070
Why?
Random Allocation
3
2015
285
0.060
Why?
Pravastatin
1
2006
18
0.060
Why?
Insulin
2
2010
479
0.060
Why?
Antineoplastic Agents
1
2014
1222
0.060
Why?
Antioxidants
1
2007
256
0.060
Why?
Constriction
1
2004
8
0.060
Why?
Platelet Aggregation
1
2005
72
0.060
Why?
Liver
1
2010
1156
0.060
Why?
Smoke
1
2004
19
0.060
Why?
Muscle, Smooth, Vascular
1
2005
133
0.060
Why?
Blood Platelets
2
2006
259
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
145
0.060
Why?
Cell Division
1
2005
291
0.060
Why?
Databases, Factual
2
2020
706
0.050
Why?
Neoplasms
1
2014
1325
0.050
Why?
Emulsions
2
2015
25
0.050
Why?
Cystathionine gamma-Lyase
1
2003
4
0.050
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.050
Why?
Endothelium, Vascular
1
2005
246
0.050
Why?
Postoperative Period
1
2004
170
0.050
Why?
Saphenous Vein
1
2004
63
0.050
Why?
Arterial Occlusive Diseases
1
2004
79
0.050
Why?
Lower Extremity
1
2004
100
0.050
Why?
Dietary Carbohydrates
1
2003
90
0.050
Why?
Oxidative Stress
1
2007
807
0.050
Why?
Dietary Fats
1
2003
130
0.050
Why?
Diet
2
2005
587
0.050
Why?
Preoperative Care
1
2004
173
0.050
Why?
Folic Acid
1
2003
140
0.050
Why?
Collagen
1
2003
211
0.050
Why?
Renal Dialysis
1
2003
179
0.050
Why?
Dose-Response Relationship, Drug
3
2011
1378
0.040
Why?
Health Care Sector
1
2020
15
0.040
Why?
Drug Industry
1
2020
40
0.040
Why?
Tomography, X-Ray Computed
2
2018
1165
0.040
Why?
Maximum Tolerated Dose
1
2019
39
0.040
Why?
alpha-Galactosidase
1
2019
9
0.040
Why?
Administration, Intravenous
1
2019
73
0.040
Why?
Disability Evaluation
1
2019
92
0.040
Why?
Multiple Myeloma
1
2013
3049
0.040
Why?
Cell Count
2
2005
149
0.040
Why?
Double-Blind Method
1
2019
713
0.030
Why?
Blotting, Western
2
2005
590
0.030
Why?
Glutamates
1
2016
21
0.030
Why?
Referral and Consultation
1
2019
292
0.030
Why?
Gene Expression Regulation
2
2011
990
0.030
Why?
Angiography
1
2016
114
0.030
Why?
Single-Blind Method
1
2015
116
0.030
Why?
Drug Evaluation, Preclinical
1
2015
146
0.030
Why?
Infusions, Intravenous
1
2015
220
0.030
Why?
Reperfusion Injury
1
2015
70
0.030
Why?
Blood Chemical Analysis
1
2014
28
0.030
Why?
Immunohistochemistry
2
2005
979
0.020
Why?
Infusion Pumps, Implantable
1
2011
14
0.020
Why?
Angioplasty
1
2011
20
0.020
Why?
Estrogen Replacement Therapy
1
2011
28
0.020
Why?
Proliferating Cell Nuclear Antigen
1
2011
69
0.020
Why?
Hyperhomocysteinemia
1
2011
29
0.020
Why?
Liver Regeneration
1
2011
47
0.020
Why?
Jugular Veins
1
2011
34
0.020
Why?
Ovariectomy
1
2011
113
0.020
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2011
59
0.020
Why?
Statistics, Nonparametric
1
2011
192
0.020
Why?
Chi-Square Distribution
1
2011
288
0.020
Why?
Vascular Endothelial Growth Factor A
1
2011
182
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2000
5
0.020
Why?
Ultrasonography, Doppler, Pulsed
1
2010
2
0.020
Why?
Injections, Intravenous
1
2010
138
0.020
Why?
Coloring Agents
1
2010
69
0.020
Why?
Phlebography
1
2010
55
0.020
Why?
Isoproterenol
1
2000
55
0.020
Why?
Luciferases
1
2000
48
0.020
Why?
Mice, Inbred Strains
1
2010
163
0.020
Why?
Epithelium
1
2000
65
0.020
Why?
Adrenergic beta-Agonists
1
2000
42
0.020
Why?
Alanine Transaminase
1
2010
122
0.020
Why?
Regional Blood Flow
1
2010
109
0.020
Why?
Cyclic AMP
1
2000
91
0.020
Why?
Blood Flow Velocity
1
2010
95
0.020
Why?
Propranolol
1
2000
78
0.020
Why?
Norepinephrine
1
2000
112
0.020
Why?
Epinephrine
1
2000
97
0.020
Why?
Transfection
1
2000
357
0.020
Why?
Cell Membrane
1
2000
245
0.020
Why?
Ultrasonography
1
2011
430
0.020
Why?
Transcription, Genetic
1
2000
378
0.020
Why?
DNA
1
2011
549
0.020
Why?
Cell Line
1
2000
1030
0.020
Why?
Malondialdehyde
1
2007
54
0.020
Why?
Blood Glucose
1
2010
473
0.020
Why?
Platelet Activation
1
2007
47
0.020
Why?
Triiodobenzoic Acids
1
2007
9
0.020
Why?
Glutathione
1
2007
305
0.020
Why?
Drug Combinations
1
2006
132
0.020
Why?
Aged, 80 and over
1
2013
3392
0.020
Why?
Contrast Media
1
2007
193
0.020
Why?
Dizocilpine Maleate
1
2005
14
0.020
Why?
Cholesterol
1
2006
153
0.010
Why?
Matrix Metalloproteinase 9
1
2005
87
0.010
Why?
Interleukin-1
1
2005
107
0.010
Why?
Excitatory Amino Acid Antagonists
1
2005
46
0.010
Why?
Homocystine
1
2004
8
0.010
Why?
DNA, Complementary
1
2005
135
0.010
Why?
Platelet Function Tests
1
2004
17
0.010
Why?
Cell Culture Techniques
1
2005
102
0.010
Why?
C-Reactive Protein
1
2006
155
0.010
Why?
Aorta, Thoracic
1
2005
97
0.010
Why?
Cotinine
1
2004
21
0.010
Why?
Probability
1
2004
172
0.010
Why?
RNA
1
2005
168
0.010
Why?
Cell Movement
1
2005
268
0.010
Why?
Reference Values
1
2004
313
0.010
Why?
Biopsy, Needle
1
2004
183
0.010
Why?
Ultrasonography, Doppler, Duplex
1
2004
21
0.010
Why?
Severity of Illness Index
1
2007
1026
0.010
Why?
Arginine
1
2005
182
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
582
0.010
Why?
Platelet Adhesiveness
1
2003
13
0.010
Why?
Nitric Oxide
1
2005
249
0.010
Why?
Elastin
1
2003
23
0.010
Why?
Signal Transduction
1
2000
1671
0.010
Why?
Polytetrafluoroethylene
1
2003
33
0.010
Why?
Anastomosis, Surgical
1
2003
68
0.010
Why?
Young Adult
1
2013
4329
0.010
Why?
Vascular Patency
1
2003
82
0.010
Why?
Dogs
1
2003
180
0.010
Why?
Graft Occlusion, Vascular
1
2003
75
0.010
Why?
Extracellular Matrix
1
2003
112
0.010
Why?
Gene Expression
1
2005
618
0.010
Why?
RNA, Messenger
1
2005
1132
0.010
Why?
Adolescent
1
2013
6739
0.010
Why?
Cells, Cultured
1
2005
1567
0.010
Why?
Cell Proliferation
1
2005
1023
0.010
Why?
Models, Biological
1
2003
735
0.010
Why?
Brown's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description